View source for Medical Reporting/Research - Academic and Professional

'''Minimal Requirement of being a verified major news outlet with a high unbiased rating on The Media Bias Chart and/or from reputable sources, such as research facilities and universities'''<br/>
<big>'''Strong recommendation to not take action or make assumptions based upon research which may be dated, changing or part of ongoing research'''</big>

'''Pre-Requisite Reading:''' [https://www.pbs.org/newshour/show/problem-thinking-know-experts The Problem with Thinking You Know More Than the Experts]

=Peer-Reviewed Research=
* 30 APR 2020 [https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31022-9/fulltext Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial]
* 27 APR 2020 [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7184987/?fbclid=IwAR01_Y5D7GRkt4Uk91nhkwzRBjdpWJlpUALdF1mA-60H1DEU0qDFIzYwl6Y Obesity: the “Achilles heel” for COVID-19?]
* 24 APR 2020 [https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3563092&fbclid=IwAR0BmVOyN2ztdniMz_ono5wfbqDwKs1QnzAKiUyApOZfMBLm9hwlXIPBt2o The Use of Povidone Iodine Nasal Spray and Mouthwash During the Current COVID-19 Pandemic May Reduce Cross Infection and Protect Healthcare Workers]
* 20 APR 2020 [https://www.medrxiv.org/content/10.1101/2020.04.16.20065920v1.full.pdf Outcomes of hydroxychloroquine usage in United States veterans hospitalized with Covid-19] - (PDF)
* 17 APR 2020 [https://www.nejm.org/doi/full/10.1056/NEJMc2009191 Guillain–Barré Syndrome Associated with SARS-CoV-2 Guillain–Barré Syndrome Associated with SARS-CoV-2]
* 14 APR 2020 [https://semmelweis.hu/english/2020/04/sigma-1-receptor-may-play-a-key-role-in-the-treatment-of-covid-19/?fbclid=IwAR0IEAXCR3mInsXJlD7zzk-Wb3a0w2NVZVTgEHgVOfrIhKDNc2rugHCAmwo SIGMA-1 RECEPTOR MAY PLAY A KEY ROLE IN THE TREATMENT OF COVID-19]
* 14 APR 2020 [https://science.sciencemag.org/content/early/2020/04/14/science.abb5793 Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period]
* 13 APR 2020 [https://ucsdnews.ucsd.edu/pressrelease/loss-of-smell-and-taste-validated-as-covid-19-symptoms-in-patients-with-high-recovery-rate Loss of Smell and Taste Validated as COVID-19 Symptoms in Patients with High Recovery Rate]
* 06 APR 2020 [https://www.medrxiv.org/content/10.1101/2020.04.06.20050575v1.full Pulmonary and Cardiac Pathology in Covid-19: The First Autopsy Series from New Orleans]
* 01 APR 2020 [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7118642/?fbclid=IwAR1eyyhDKALUT96uGguXuvWbx3AE4UbtDHV77mo0bSzwHqdL9e8Jvi1NpnQ Potential effect of blood purification therapy in reducing cytokine storm as a late complication of critically ill COVID-19]
* 24 MAR 2020 [https://www.fda.gov/emergency-preparedness-and-response/mcm-regulatory-science/investigating-decontamination-and-reuse-respirators-public-health-emergencies Investigating Decontamination and Reuse of Respirators in Public Health Emergencies]
* 10 MAR 2020 [https://annals.org/aim/fullarticle/2762808/incubation-period-coronavirus-disease-2019-covid-19-from-publicly-reported The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application]
* 25 FEB 2020 [https://www.tandfonline.com/doi/full/10.1080/22221751.2020.1745095 Laboratory diagnosis of emerging human coronavirus infections – the state of the art]
* 14 FEB 2020 [https://www.nature.com/articles/s41413-020-0084-5?fbclid=IwAR3rT2gIUHc4Ssi9GD1aE74Ri8oVSuOwPui_RQiXvoPfR6gYxFZifLy74r4 Long-term bone and lung consequences associated with hospital-acquired severe acute respiratory syndrome: a 15-year follow-up from a prospective cohort study]
* 06 FEB 2020 [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7014672/ Incubation period of 2019 novel coronavirus (2019-nCoV) infections among travellers from Wuhan, China, 20–28 January 2020]
* 00 SEP 2015 [https://pubmed.ncbi.nlm.nih.gov/26133021/ Brief Report: Incubation Period Duration and Severity of Clinical Disease Following Severe Acute Respiratory Syndrome Coronavirus Infection]

=Pre-Reviewed Studies=

* 10 APR 2020 [https://www.medrxiv.org/content/10.1101/2020.04.10.20060558v1 Hydroxychloroquine in patients with COVID-19: an open-label, randomized, controlled trial] - 
* 13 FEB 2020 [https://www.medrxiv.org/content/10.1101/2020.02.12.20022418v1 ACE2 Expression in Kidney and Testis May Cause Kidney and Testis Damage After 2019-nCoV Infection] 



[[Category: Medical Reporting]][[Category: Research]]